Irreversible Antagonists for the Adenosine A<sub>2B</sub> Receptor
Blockade of the adenosine A<sub>2B</sub> receptor (A<sub>2B</sub>AR) represents a potential novel strategy for the immunotherapy of cancer. In the present study, we designed, synthesized, and characterized irreversible A<sub>2B</sub>AR antagonists based on an 8-&l...
Main Authors: | Ahmed Temirak, Jonathan G. Schlegel, Jan H. Voss, Victoria J. Vaaßen, Christin Vielmuth, Tobias Claff, Christa E. Müller |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/12/3792 |
Similar Items
-
New heterocyclic A1/A3 adenosine receptor ligands through molecular simplification strategies
by: Letizia Crocetti, et al.
Published: (2025-04-01) -
The Pharmacological Potential of Adenosine A<sub>2A</sub> Receptor Antagonists for Treating Parkinson’s Disease
by: Akihisa Mori, et al.
Published: (2022-04-01) -
REGA-SIGN: Development of a Novel Set of NanoBRET-Based G Protein Biosensors
by: Katrijn Boon, et al.
Published: (2023-07-01) -
Imaging of Gα<sub>q</sub> Proteins in Mouse and Human Organs and Tissues
by: Jan H. Voss, et al.
Published: (2022-12-01) -
A<sub>3</sub> Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
by: Andrea Spinaci, et al.
Published: (2022-01-01)